$1 Dollar Liquid Based Biopsy Device Offers Way to Monitor Cancer Patients

| February 15, 2014

liquid-biospy-device_byMassGeneralHospital-300x225Courtesy of Dark Daily:

Pathologists will be interested to learn that researchers at Harvard Medical School and Massachusetts General Hospital are developing a “liquid biopsy” technology specifically to enable point-of-care monitoring of the progress of patients undergoing treatment for certain types of cancers.

The goal is to develop a method that community hospitals can use to monitor treatment of ovarian cancer patients without the need for expensive medical laboratory equipment, noted a report published by Biosciencetechnology.com. Researchers estimate that their ‘liquid biopsy’ technology could cost as little as $1 per test when eventually cleared for use in clinical settings.

The research team created a microchip device—called the ATC chip—that simplifies monitoring of a patient’s response to treatment for ovarian cancer and certain other malignancies. The device captures, isolates, and identifies tumor cells from ascites (ATCs).

Read more.

Tags: , , , ,

Category: Anatomic Pathology, Clinical Laboratories, General Healthcare News, Medical Research, Pathology News, Web/Tech

Comments are closed.